Bei Akademie registrieren
Vertex Pharma, US92532F1003

Vertex Pharma stock trades at EUR 445.78 as Vertex reports ALYFTREK data

Published on 10/18/2026 at 17:35 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Vertex Pharma stock trades at EUR 445.78 in weekend trading on October 18, 2026. Vertex reported ALYFTREK data from 48 children on October 9, 2026.

Clinical update and schedule

  • Vertex reported interim ALYFTREK data from 48 children on October 9, 2026.
  • Vertex Pharma stock trades in weekend trading at EUR 445.78 at 5:31 p.m. CEST on October 18, 2026.
  • The next Xetra session is scheduled for October 19, 2026, and Vertex plans to report third-quarter results on November 2, 2026.
Flatlay-Anordnung mit Zertifikat, ISIN-Karte, Pipette, Fläschchen und Stethoskop
Vertex Pharma US92532F1003 präsentiert eine Flatlay-Anordnung mit Aktienzertifikat, ISIN-Karte und typischen Laborutensilien, Illustration mit AI erstellt.

Vertex Pharmaceuticals Incorporated announced interim ALYFTREK data from 48 children on October 9, 2026, in a company release. The company said the data concerned children ages 2 to 5 with cystic fibrosis who received vanzacaftor/tezacaftor/deutivacaftor in an open-label extension study.

Vertex Pharma stock was at EUR 445.78 in weekend trading at Lang & Schwarz at 5:31 p.m. CEST on October 18, 2026. The quote page reported a bid of EUR 444.90 and an ask of EUR 446.65.

Vertex said 18 of the 48 children eligible for the pancreatic enzyme replacement therapy discontinuation substudy, or 37.50 percent, had successfully discontinued treatment for a mean duration of 8.60 weeks at the interim analysis. The company also reported that mean fecal elastase-1 was 239.70 micrograms per gram, with 48.60 percent of children reaching the pancreatic sufficiency threshold. The use of ALYFTREK in children ages 2 to 5 remains investigational, according to the release.

Market context: Market report Nasdaq Composite.

Weekend trading

The quote is the latest indication from Lang & Schwarz during the weekend session. The further course of weekend trading at Lang & Schwarz until 7:00 p.m. CET/CEST is shown by the continuously updated real-time quote of Vertex Pharma stock.

Upcoming company dates

The next Xetra session is scheduled for October 19, 2026. Vertex has announced that it will report its third-quarter 2026 financial results on November 2, 2026, after the financial markets close, with a conference call and webcast scheduled for 4:30 p.m. Eastern Time, according to a company announcement.

Disclaimer...
en | US92532F1003 | VERTEX PHARMA | boerse | 70354783 | bgmi